Calendar Senti Biosciences, Inc.

Equities

SNTI

US81726A1007

End-of-day quote Nasdaq 23:00:00 25/04/2024 BST 5-day change 1st Jan Change
0.29 USD +4.05% Intraday chart for Senti Biosciences, Inc. -5.69% -56.06%

Chart calendar Senti Biosciences, Inc.

fa4b.IwIZAIx12qu6jArr2fGLTqQCsS_JabhUgV0fphqiUMk.cktQV9U-n-rJ3Xu4qr7AEetd9WeOC5Vsx2VW9W_AYKJMSUBO-DOLmYvIWw~12b5bb30107027adc5a1128c72d98009

Upcoming events on Senti Biosciences, Inc.

06/05/2024 Q1 2024 Earnings Release (Projected)
11/08/2024 Q2 2024 Earnings Release (Projected)
06/11/2024 Q3 2024 Earnings Release (Projected)
19/03/2025 Q4 2024 Earnings Release (Projected)

Past events on Senti Biosciences, Inc.

21/03/2024 20:05 Q4 2023 Earnings Release
08/12/2023 American Society of Hematology Meeting
13/11/2023 21:15 Q3 2023 Earnings Release
04/11/2023 16:00 Society for Immunotherapy of Cancer Meeting - Abstract number: 270
04/11/2023 16:00 Society for Immunotherapy of Cancer Meeting - Abstract number: 430
04/11/2023 16:00 Society for Immunotherapy of Cancer Meeting - Abstract number: 24
03/11/2023 16:00 Society for Immunotherapy of Cancer Meeting - Abstract number: 257
11/10/2023 23:15 Cell & Gene Meeting on the Mesa Conference
10/10/2023 15:45 Cell & Gene Meeting on the Mesa Conference - Panel
03/10/2023 18:30 Chardan Genetic Medicines Conference
25/09/2023 Society for Natural Immunity Meeting
13/09/2023 19:55 Morgan Stanley Global Healthcare Conference
11/09/2023 12:00 H.C. Wainwright Global Investment Conference
11/08/2023 13:35 Q2 2023 Earnings Release
16/06/2023 16:00 Annual General Meeting
20/05/2023 16:15 American Society of Gene Cell Therapy Meeting - Abstract No: 341
19/05/2023 20:00 American Society of Gene and Cell Therapy Meeting - Abstract No: 1535
19/05/2023 20:00 American Society of Gene and Cell Therapy Meeting - Abstract No: 1408
18/05/2023 23:00 American Society of Gene Cell Therapy Meeting - Abstract No: 150
15/05/2023 19:30 JMP Securities Life Sciences Conference

Annual results

Fiscal PeriodDecember 2021 2022
Net sales
Million USD
Released
Forecast
Spread
0,00


4,29
5,33
-19.59%
EBITDA
Million USD
Released
Forecast
Spread
0,00


-69,2
-69,7
0.66%
EBIT
Million USD
Released
Forecast
Spread
0,00


-70,6
-71,0
0.58%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


-58,2
-59,3
1.82%
Net income
Million USD
Released
Forecast
Spread
-55,3


-58,2
-60,3
3.4%
EPS
USD
Released
Forecast
Spread
-3,72


-2,23
-1,92
-16.35%
Announcement Date01/04/2222/03/23

Quarterly results

Fiscal PeriodDecember 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3
Net sales
Million USD
Released
Forecast
Spread
1,77
0,93
90.1%
0,06
1,56
-96.21%
1,29
0,70
83.71%
0,94
0,75
24.93%
0,34
0,70
-51.71%
EBITDA
Million USD
Released
Forecast
Spread



-19,6
-22,2
11.9%









EBIT
Million USD
Released
Forecast
Spread
-17,1
-21,7
21.39%
-20,0
-20,1
0.44%
-19,8
-21,6
8.31%
-19,6
-21,8
10.06%
-18,2
-20,0
9.08%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread



-18,2
-17,0
-7.12%
-18,7
-19,0
1.46%
-18,7
-20,0
6.52%
-36,6
-19,0
-92.71%
Net income
Million USD
Released
Forecast
Spread
-16,6
-21,7
23.35%
-18,2
-19,6
7.11%
-18,7
-21,0
10.78%
-18,7
-21,2
11.74%
-36,6
-19,0
-92.71%
EPS
USD
Released
Forecast
Spread
-0,38
-0,50
24%
-0,42
-0,47
10%
-0,42
-0,48
11.58%
-0,42
-0,48
11.72%
-0,34
-0,44
23.08%
Announcement Date10/11/2222/03/2309/05/2311/08/2314/11/23

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. SNTI Stock
  4. Calendar Senti Biosciences, Inc.